You are here: Industry Insights > Pfizer

News List

Real-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVID-19 drugs
June 09, 2021
A real-world study shows that even when people who get the Pfizer and Moderna COVID-19 vaccines do have "breakthrough" infections, those illnesses are mild.
Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO fiercepharma
September 28, 2018
The race is on for a next-generation pneumococcal vaccine. Merck has already pushed its 15-valent candidate into phase 3, and on Thursday, Pfizer CFO Frank D’Amelio said his company is “all in” on reaching the market as
Takeda's Alunbrig trounces Pfizer drug in bid for earlier ALK lung cancer use fiercepharma
September 27, 2018
Pfizer’s targeted therapy Xalkori is about to get even more competition in previously untreated ALK-positive lung cancer. And if new data are any indication, it’s pretty stiff.
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive fiercepharma
August 01, 2018
Last year, Pfizer and Bristol-Myers Squibb’s Eliquis replaced Johnson & Johnson’s Xarelto as the leader of the novel oral anticoagulant class. And now it’s about to unseat an even bigger foe: warfarin.
Adapsyn Bioscience announces research collaboration with Pfizer Inc. biospectrumasia
January 12, 2018
In addition, the company has announced research collaboration with Pfizer Inc.
NICE to take another look at Pfizer’s leukaemia drug pharmafile
January 03, 2018
Back in August of 2017, NICE rejected Pfizer’s Besponsa on cost-effectiveness grounds and the pharma giant was not best pleased.
AbbVie, Pfizer Jump in on Newly-Launched Jnana Therapeutics' $50M Funding Round biospace
December 18, 2017
Jnana Therapeutics launched with a $50 million Series A financing yesterday. Seed funders Polaris Partners and Avalon Ventures were joined in the round by Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate.
Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense biospace
November 15, 2017
Investors love to speculate on mergers and acquisitions (M&A), and one of the hottest topics of speculation recently has been whether someone will buy Bristol-Myers Squibb.
Reckitt Benckiser's still wantx to buy Pfizer's OTC business. But what does money say? fiercepharma
October 17, 2017
Reckitt Benckiser’s feelings about Pfizer’s consumer unit haven’t changed since the company said in 2015 that it’d be keen to buy it. But its resources have.
LabCentral, Pfizer to Open Next-Stage Facility contractpharma
September 25, 2017
LabCentral and Pfizer plans to open LabCentral 610, a new lab offering located at Pfizer’s Kendall Square Worldwide R&D campus.

Previous page 1 2 Next page